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ABSTRACT 
 
 
            Argonaute protein is a vital component in the RNA interference pathway and 
post-transcriptional gene regulation in eukaryotes and the protein was recently identified 
in Toxoplasma gondii. However, the molecular mechanism by which the argonaute 
protein participates in regulating gene regulation pathways is unclear. This study was 
aimed to investigate the presence of argonaute protein variants in T. gondii (TgAgo), and 
its contribution in post-transcriptional gene silencing pathway. Furthermore, the study 
was designed to elucidate the influence of TgAgo on parasite growth and bradyzoite 
development. Using PCR analysis, I did not detect any transcript variants of TgAgo. A 
single transcript of TgAgo was identified to have 2,232 nucleotides encompassing 5 
exons. Protein immunoblot assay showed a single protein of ~58.5 kDa. Gene silencing 
assays demonstrated that knockout of argonaute expression (AGOKO) reduced the gene 
silencing ability of an RNAi-like mechanisms in T. gondii, suggesting the importance of 
TgAgo in post transcriptional gene regulation pathways. T. gondii growth pattern was 
unaffected by the removal of Ago expression. However, bradyzoite formation was 
increased in AGOKO strains. The study suggests that TgAgo is a vital component of 
bradyzoite formation in the life cycle of T. gondii. 
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Chapter 1 
Literature Review 
 
 
 
 
1.1 Discovery of the Toxoplasma gondii 
 
            Toxoplasma gondii is a ubiquitous, obligate intracellular protozoan parasite 
belonging to the phylum Apicomplexa. Other pathogenic members in this phylum include 
Plasmodium, Eimeria, Neospora, Babesia, Theileria and Cryptosporidium (Kim and 
Weiss, 2004; Echeverria et al., 2010).  T. gondii has the ability to infect a variety of 
warm-blooded vertebrates including humans, and causes frequent infections in wild, 
domesticated and companion animals (Hunter and Sibley, 2012). One third of the human 
population worldwide is anticipated to have T. gondii infection which can lead to the 
development of toxoplasmosis (Hoffmann et al., 2012). 
            T. gondii was first discovered by Nicolle and Manceaux in 1908 in tissues of a 
species of a North African hamster-like rodent (Ctenodactylus gundi; Tenter et al., 2000). 
In the late 1960s, an infectious stage of T. gondii was found in cat faeces, which was 
recognized as infectious to other hosts (intermediate hosts). Following that, in 1970, 
sexual stages were first defined in the small intestine of cats and the two phase (Sexual 
and asexual) life cycle of T. gondii was defined (Frenkel et al., 1970; Tenter et al., 2000; 
Dubey, 2009).   
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 1.2 Life cycle 
             T. gondii has the ability to infect and replicate within virtually any nucleated 
mammalian or avian cell. The life cycle of T. gondii is facultatively heteroxenous, 
whereas it can complete its life cycle without intermediate host. The life cycle comprises 
two phases; the sexual phase within the feline (definitive host) and the asexual phase that 
takes place within non-feline hosts (intermediate host) (Tenter et al., 2000; Black and 
Boothroyd, 2000). The life cycle is summarized schematically in Figure 1.1. T. gondii 
exhibits three infectious forms namely tachyzoites, bradyzoites (in tissue cysts), and 
sporozoites (in oocysts) throughout its life cycle in different hosts (Dubey, 2006).      
 
1.3 Mode of transmission 
            T. gondii can be transmitted through vertically as well as horizontally. Tachyzoite 
forms can transmit vertically from mother to foetus through placenta during pregnancy. 
However, horizontal transmission occurs via ingesting tissue cysts from undercooked 
meat, consuming oocysts from contaminated food or drink, or accidental ingestion of 
oocysts from the environment. Furthermore, tachyzoites may transmit during blood 
transfusion from an infected donor to recipient and also during tissue transplantation. 
Breastfeeding is another source of T. gondii transmission from the infected mother to the 
offspring (Tenter et al., 2000; Dubey, 2009).   
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Figure 1.1: Diagram representing the life cycle of T.  gondii.  A sexual cycle takes 
place within intestinal cells of felines where male and female gametes are formed. Male 
gamete fertilizes the female gamete and giving rise to the oocysts, which are shed 
through faeces and contaminate the external environment (food, water) and provides a 
route of infection for intermediate hosts. An asexual cycle occurs within the intermediate 
hosts (mammals, birds, and almost in any warm-blooded organisms) where they can 
produce acute infection by rapidly growing tachyzoites or can differentiate into slow 
growing bradyzoites within the tissue cysts, leading to chronic infection. Ingestion of 
tissue cysts is also the primary source of T. gondii infection for both definitive and 
intermediate hosts (Hunter and Sibley, 2012). 
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1.4 Sexual life cycle 
  
            The sexual cycle occurs in the definitive host (felines). Felines can be infected 
with any of the three infectious stages of T. gondii, i.e. tachyzoites, bradyzoites (in tissue 
cysts), and sporozoites (in oocysts; Dubey, 2006), although infection with bradyzoites is 
more pathogenic than infection with either oocysts or tachyzoites (Dubey, 1998; Dubey, 
2006). After entering into the host, bradyzoites reproduce in the enterocytes by 
endodyogeny, followed by repeated endopolygeny. Afterwards, it develops to gametes 
(gamogony) and initiates the sexual cycle. The male gamete fertilizes the female gamete, 
and two walls are formed around the fertilized zygote to form the oocyst (Dubey, 2016). 
Subsequently, unsporulated oocysts are released into the environment through faeces. 
Sporogony formation occurs outside the host and leads to the development of highly 
infectious and extremely stable oocysts containing two sporocysts where each sporocysts 
contains four sporozoites (Tenter et al., 2000; Boothroyd and Grigg, 2002).   
 
1.5 Asexual life cycle 
 
            The intermediate host (humans, animals) can be infected via any of the three 
infectious stages of T. gondii.  In the intermediate host, T. gondii undergoes the asexual 
replication. Upon ingestion of oocyst, the sporozoites form parasitophorous vacuoles 
(PV) in the small intestinal simple columnar epithelial cells (enterocytes) without 
infection and a few sporozoites enter in the lamina propria cells. The sporozoites first 
enter in the enterocytes but develop in the lamina propria cells. In the lamina propria the 
sporozoites convert to tachyzoites and then infect the enterocytes, as well as the capillary 
endothelial cells, macrophages, plasma cells, lymphocytes, neutrophils, eosinophils, 
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smooth muscle cells and fibrobroblasts (Dubey et al., 1998). On the other hand, if 
bradyzoites are ingested, a proportion of bradyzoites are destroyed in the lumen of the gut 
and others convert to tachyzoites in the small intestinal lamina propria and migrate to 
extraintestinal organs. In the intermediate hosts, T. gondii undergoes two phases of 
asexual development. In the first phase, tachyzoites (or endozoites) multiply swiftly by 
repeated endodyogeny in the host cells and eventually rupture the host cells and migrate 
to attach, invade and colonize a new host cell (Dubey et al., 1998) and this repeated cycle 
is known as the lytic cycle of T. gondii (Black and Boothroyd, 2000; Figure 1.2). 
Tachyzoites spread throughout all tissues in the body but differentiate into the dormant 
bradyzoite stage upon exposure to a potent host immune response (Skariah et al., 2010) 
and begin the second phase of development which results in the formation of tissue cysts. 
Within the tissue cyst, bradyzoites (or cystozoites) multiply slowly by endodyogeny 
(Tenter et al., 2000). Cyst formation is predominantly found in the central nervous 
system (CNS), eye and also in the skeletal and cardiac muscles. Cysts may also be found 
in visceral organs, such as lungs, liver, and kidneys.  Tissue cysts are the terminal life-
cycle stage in the intermediate host where they may persist for life or may break down 
the cysts and bradyzoites can transform to tachyzoites which may re-infect the host cells 
and again transform to bradyzoites within new tissue cysts (Tenter et al., 2000; Cenci-
Goga et al., 2011).   
 
1.6 Tachyzoite to bradyzoite interconversion 
            Tachyzoites and bradyzoites are two discrete stages in the asexual cycle of T. 
gondii (Tenter et al., 2000; Dubey et al., 1998). Tachyzoites are the rapidly growing form 
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of the parasite and exhibits acute infection in an immunocompromised host. Tachyzoites 
are often crescent shaped of approximately 5 µm long and 2 µm wide (Black and 
Boothroyd, 2000; Dubey et al., 1998) and enter into host cells through the initial 
recognition of the cell surface glycoproteins of the host cells by the help of tachyzoite 
specific surface antigen SAG1 (Black and Boothroyd, 2000). 
            Bradyzoites are the dormant form of T. gondii, grows slowly and generate tissue 
cysts within the host and causes the chronic infection. Bradyzoites remain intracellular 
and divide by the endodyogeny process.  Tissue cysts can vary in sizes based on the 
number of bradyzoites contains in the cyst (Dubey et al., 1998). The tissue cyst develops 
by modifying the parasitophorous vacuole into an elastic, glycoprotein-rich protective 
cyst wall which is the key structural feature for bradyzoites conversion (Tomita et al., 
2013). This cyst wall is easily detectable in culture by fluorescently labeled Dolichos 
biflorus lectin which binds the glycoprotein CST1 (Zhang et al., 2001; Tomita et al., 
2013). Moreover, bradyzoites are influenced to up-regulate the stage-specific 
transcription of genes such as the heat shock protein bradyzoite antigen 1 (BAG1) 
(Bohne et al., 1997), the metabolic enzymes lactate dehydrogenase isoenzyme 2 (LDH2) 
and enolase isoenzyme 1 (ENO1) to adapt to adverse conditions. On the other hand, 
down regulate the tachyzoite-specific lactate dehydrogenase isoenzyme 1 (LDH1), 
enolase isoenzyme 2 (ENO2), and surface antigen 1 (SAG1) proteins (Yang and Parmley, 
1997; Dzierszinski et al., 2001; Ferguson, 2004).   
            In vitro studies for understanding the mechanism behind the interconversion 
between tachyzoite and bradyzoite are convenient than in vivo studies (Skariah et al., 
2010). Getting large amounts of encysted bradyzoites in vivo for study is challenging, but 
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in vitro studies allow for large scale simultaneous conversion to bradyzoites, providing an 
understanding of the process in detail and study of the mechanisms involved. 
Furthermore, the in vitro cysts have been shown to be similar to in vivo cysts.   
            There are a variety of methods that can be utilized to initiate in vitro bradyzoite 
conversion from tachyzoite. Modifying the culture conditions or chemical treatments are 
the effective methods assaying for differentiation. The methods includes, changing the 
pH of the culturing media (pH 8.0-8.2), raising the incubation temperature from 37°C to 
43°C or sodium arsenite treatment (Soete et al., 1994). Moreover, the treatment with 
interferon (IFN)-γ (Bohne et al., 1993), mitochondrial inhibitors (antimycin A, 
myxothiazol, oligomycin; Bohne et al., 1994) and increasing the levels of cyclic 
nucleotides (Kirkman et al., 2001) can also facilitates into bradyzoites differentiation.     
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Figure 1.2: Lytic cycle of T. gondii. Extracellular parasites first attach and invade the 
host cell. After entering the host cell, the parasites become surrounded by 
parasitophorous vacuole (PV). In the PV the parasites undergo several rounds of 
replication until lysed from the host cells, motile parasites are released which migrate 
towards and invade a new host cell (Blader et al., 2015). 
 
1.7 T.  gondii as a model apicomplexan organism 
            There are several pathogenic members in the phylum Apicomplexa which cause 
different diseases. Plasmodium species infect human red blood cells causing malaria 
(Cowman and Crabb, 2002). Eimeria and Cryptosporidium cause enteric disease, while 
Neospora and Theileria are systemic veterinary pathogens. Experimenting with these 
parasites is highly challenging due to the difficulty of culturing and maintaining them in 
the laboratory (Kim and Weiss, 2004). However, T. gondii is experimentally tractable to 
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maintain in the lab, as well as readily amenable to genetic manipulation. This allows for 
high efficiency transient and stable transfection, as well as provides the opportunity to do 
research with diverse cell markers (Roos et al., 1995; Kim and Weiss, 2004). Moreover, 
T. gondii is relatively convenient for advanced microscopic analyses, which also makes 
T. gondii a good model apicomplexan organism (Kim and Weiss, 2004).  
    
1.8 Genotypes and Clonal Lineages of T. gondii 
            T. gondii has three clonal lineages, known as types I (RH and GT-1), type II 
(ME49 and its derivatives PDS, PLK, PTG) and type III (CTG and VEG) respectively. 
Genome sequence analyses indicated the sequences similarities are high (99% or more 
between strains) for the 3 major lineages (Howe and Sibley, 1995; Su et al., 2003; Saeij 
et al., 2005).  The strains are found in a variety of hosts from various geographic regions 
positioned primarily in North America and Europe (Howe and Sibley, 1995). Among 
them, type I strains are most pathogenic and can cause 100% mortality in mouse model 
with a small number of parasites and significantly higher levels of parasitema. However, 
type I strains have less potential to form cysts in culture and in animals. Additionally, 
type I strains are significantly more common in human congenital and ocular 
toxoplasmosis. On the contrary, type II strains are less virulent, but are the most prevalent 
clinical isolates, responsible for almost two-thirds of human cases of toxoplasmosis and 
considerably more common in AIDS patients with toxoplasmosis. Besides this, type II 
strains produce a higher number of cysts and are associated with reactivation of chronic 
infection. Type III strains are also less virulent and are more common in animal than 
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human hosts (Derouin and Garin, 1991; Howe and Sibley, 1995; Boothroyd and Grigg, 
2002; Kim & Weiss, 2004).           
 
1.9 Regulation of gene expression 
            Gene expression is the collective process that includes transcriptional, post-
transcriptional and post-translational regulatory events to synthesize the functional gene 
product from the genetic information. The gene products can be regulatory molecules, 
enzymes or structural protein molecules to serve the major structural elements of living 
systems (Petsko and Ringe, 2004). The regulation of gene expression is imperative to 
ensure the proper level of gene expression and maintain accurate biological functions, 
cellular differentiation, morphogenesis and the versatility and adaptability necessary for 
the cellular survival (Halbeisen et al., 2008). 
            Transcriptional gene regulation is achieved through the direct interaction among 
the controlling factors (transcription factors), where these controlling factors are proteins 
in nature (Starr and Starr, 2014). Regulatory DNA binding sites or elements are known as 
enhancers, insulators and silencers.  Furthermore, the transcription factors can be 
modified by intracellular signals through protein post-translational modification 
processes including phosphorylation, acetylation, or glycosylation. These modulated 
control factors influence the ability of transcription factors to interact with the 
transcription machinery to facilitate transcriptional regulation. In addition to this, 
epigenetics has a great influence on gene expression, which relies on non-sequence based 
changes in DNA structure such as DNA methylation and histone modification that alter 
the accessibility of DNA to transcription factors and modulate transcription levels (Starr 
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and Starr, 2014; Phillips, 2008). In the DNA methylation process, methyl groups are 
added to the fifth carbon atom of a cytosine ring (5-methylcytosine) of eukaryotic DNA 
by DNA methyltransferases. These altered cytosine residues usually positioned 
immediately next to a guanine base (CpG methylation) and two methylated cytosines 
placed diagonally to each other on opposite strands of DNA and can lead to inappropriate 
regulation of gene expression (Phillips, 2008). Histone modifications include lysine 
acetylation, lysine and arginine methylation, serine and threonine phosphorylation, and 
lysine ubiquitination and sumoylation, which can modify chromatin structure into active 
euchromatin (DNA is accessible for transcription) or inactive heterochromatin (DNA is 
more compact and less accessible for transcription) and regulate transcription (Vaquero et 
al., 2003; Starr and Starr, 2014). Transcriptional gene regulation occurs in different 
tissues, developmental stages, and under different environmental conditions, however the 
process is relatively slow and insufficient to rapidly and precisely modulate gene 
expression compared to post-transcriptional gene regulation (PTGR; Hall et al., 2005; 
Moore, 2005).   
            Post-transcriptional regulation is the regulation of gene expression after synthesis 
of the mRNA, but before translation. mRNA biogenesis is regulated by the formation of 
mRNPs (mRNA binding proteins; Moore, 2005). The components of the mRNP guide the 
transcript to specific biological processes by recognizing the cis-acting elements of the 
transcript (typically at the 5’ and 3’ UTR of the transcript), and its subsequent ability to 
recruit certain RNA-binding proteins (RBPs) through their RNA recognition motif 
(RRM; Moore et al., 2005). Therefore, all PTGR (post-transcriptional gene regulation) 
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mechanisms depend on the interaction between cis-acting elements encoded within the 
transcript and the trans-acting factors that bind and recognize them (Moore, 2005). 
            The pre-mRNA is synthesized in the nucleus and undergoes several post-
transcriptional modifications to become a mature mRNA before being exported to the 
cytoplasm. Major modifications include (i) acquisition of a 5' cap structure; (ii) splicing 
out of introns; and (iii) addition of a polyadenylated (poly A) tail at the 3ʹ end, followed 
by nuclear export to cytoplasm.   
            The addition of the 5' cap structure with pre-mRNAs is a vital co-transcriptional 
maturation process (Furuichi and Shatkin, 1989). The 5’ end m7G (7-methylguanosine) 
capping is the most universally recognizable cis-acting element (Topisirovic et al., 2011), 
which protects the mRNA from degradation by 5’ to 3’ exonucleases (Moore, 2005; 
Carmody and Wente, 2009; Furuichi and Shatkin, 1989). 5’ capping is carried out by a 
series of enzymatic reactions, which start when the primary transcript is 20-30 
nucleotides long. The enzymes involved in this process include nucleotide triphosphatase, 
guanylyltransferase, and N7-methyltransferase (Topisirovic et al., 2011). The m7G cap 
then recruits the cap binding complex for transporting the transcript to the cytoplasm 
(Proudfoot et al., 2002).  
            Cleavage of 3’ end and subsequent polyadenylation at the 3’ end of the pre-
mRNA is also an important process for maturation and mRNA stability (Darnell, 2013).  
The presence of the polyadenylation signal sequence near the 3' end of the pre mRNA 
allows the cleavage and polyadenylation specificity factors (CPSF) to bind to pre-mRNA 
(Gruber et al., 2014). Following that the pre mRNA is cleaved at a site present between a 
highly conserved AAUAAA sequence and a uracil (U) or GU-rich motif, located further 
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downstream on the pre-mRNA (Proudfoot et al., 2002). The transcript then recruits 
nuclear poly (A) polymerase (PAP) within the cleavage reaction complex which 
catalyzes the addition of the poly (A) tail (Gruber et al., 2014; Proudfoot et al., 2002). 
This template-independent polymerase generates a tail of between 200 to 250 adenosines 
which protects the 3' end from ribonuclease digestion. The Poly (A) tail then binds with 
nuclear poly (A)-binding protein to export mRNA from the nucleus to the cytoplasm 
(Gruber et al., 2014) where it is capable of either undergoing active translation or 
becoming translationally repressed.  Many genes have more than one polyadenylation 
site. Aalternative polyadenylation controls the inclusion or exclusion of cis-acting 
elements, including potential microRNA-binding sites, within its 3’ untranslated region 
(UTR) which can restrain the translatability and stability of the transcript (Gruber et al., 
2014; Sandberg et al., 2008; Liu et al., 2007). On the other hand, alternative 
polyadenylation may produce multiple transcripts (mRNA) from a single gene, which can 
code for a different protein though this is the less common process (Shen et al., 2008).     
            Splicing out of introns from pre mRNA is the final step to produce mature 
mRNA. Predominantly splicing occurs after complete synthesis of transcript with 
polyadenylation. However, in some cases splicing can occur co-transcriptionally 
(Darnell, 2013). The splicing process involves the participation of a donor site (5' end of 
the intron) with GU consensus sequence, a branch site (near the 3' end of the intron) with 
a highly conserved adenosine (A) nucleotide involved in lariat formation, and an acceptor 
site (3' end of the intron) with AG consensus sequence (Proudfoot et al., 2002).  Most 
introns follow the GU-AG rule while there are some exceptions with the ends GC-AG or 
AU-AC (Lewin et al., 2004; Proudfoot et al., 2002). The splicing reaction is catalyzed by 
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spliceosome, a large RNA-protein complex. Spliceosome are composed of protein (U2 
small nuclear RNA auxiliary factor 1 (U2AF35), U2AF2 (U2AF65) and SF1) and five 
small nuclear ribonucleoproteins (snRNPs: U1, U2, U4, U5, and U6) that recognize 
splice sites in the pre-mRNA sequence (Lewin et al., 2004; Proudfoot et al., 2002; Black, 
2003).  The spliceosome reactions involves remove the intron as a form of lariat structure 
and eventually connects the adjacent exons with the linkage of 5’ and 3’ exons (Lewin et 
al., 2004; Darnell, 2013).  
             Alternative splice sites may generate a series of different transcripts and can 
produce multiple protein isoforms from a single genomic locus (Matlin et al., 2005; 
Hassan et al., 2012). It is expected that 95% of the transcripts originating from genes with 
multiple exons undergo alternative splicing, and this occurs in a tissue-specific manner 
and/or under specific cellular conditions (Pan et al., 2008). However, alternative splicing 
may down regulate gene expression post-transcriptionally by improper splicing of the 
transcript which can target mRNAs for nonsense-mediated decay (Matlin et al., 2005; 
Lewis et al., 2003). Studies have revealed that T. gondii utilizes functional splicing 
machinery and contain the canonical 5’ GU-AG 3’ splice junction. Moreover, recent 
studies have discovered that T. gondii also uses alternative splicing to regulate gene 
expression post-transcriptionally (Suvorova and White, 2014).      
            The mature transcript is exported to the cytoplasm through the nuclear pores, and 
undergoes protein synthesis (Köhler and Hurt, 2007). In most circumstances, mRNA 
assembles into ribonucleoprotein (RNP) complexes which recruit their exporters by class-
specific adaptor proteins to transport the transcript (Köhler and Hurt, 2007). Mature 
mRNA consists of three parts: 5' untranslated region (5' UTR), protein-coding region or 
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open reading frame (ORF), and 3' untranslated region (3' UTR). The coding region 
encodes the information for protein synthesis. The mRNA codes for a single protein 
sequence, it is known as monocistronic and is common in eukaryotes. Where a given 
mRNA codes for multiple proteins, it is known as polycistronic and is common in 
prokaryotes (Lewin et al., 2004). The regulation of gene expression is also controlled 
through the processes of (i) translation, (ii) mRNA degradation (decay) and (iii) mRNA 
storage (Erickson and Lykke-Andersen, 2011).  
            During translation, the transcript is recruited into the translational machinery. 
Recognition of m7G 5'-cap structure by the eukaryotic initiation factors (eIFs) which 
form the eIF4F complex is the most common approach of translational initiation to 
produce the protein in eukaryotes. The eIF4F complex is comprised of eIF4E (cap 
binding protein), eIF4A (DEAD-box helicase) and eIF4G (scaffolding protein). eIF4E 
interacts with the 5’ cap of the transcript and also with eIF4G (López-Lastra et al., 2005; 
Sonenberg and Hinnebusch, 2009). eIF4G interacts with PABP (Poly A binding protein) 
and potentially circularizes the mRNA in the closed loop model (Malys and McCarthy, 
2011; Wells et al., 1998). Afterwards, the closed loop structure recruitments the pre-
initiation complex which contains the small ribosomal 40S subunit and the initiation 
factors including Met-tRNAi and eIF2-GTP (Sonenberg and Hinnebusch, 2009). Upon 
recruitment of the pre-initiation complex, the scanning process moves along the mRNA 
chain toward its 3'-end to reach the start codon (typically AUG). Following the 
recognition of the start codon eIF2-GTP is hydrolyzed to eIF2-GDP and recruits the 60S 
ribosomal subunit. The translational process continues until the stop codon, where the 
termination signal dissociates the ribosome (Sonenberg and Hinnebusch, 2009).   
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            Cap-independent translation initiation is an alternate translational process for 
specific mRNAs in eukaryotes which occurs during cellular stress when overall 
translation is reduced. In cap-independent translation, recognition of the 5’ cap is not 
necessary to initiate the scanning from the 5' end of the mRNA to the start codon for 
translational start. Instead an internal ribosome entry site (IRES), aids in the assembly of 
the translational machinery at a position close to the initiation codon (López-Lastra et al., 
2005).     
            Gene expression can be regulated either through the global translational 
repression of most of the transcripts or by transcript-specific translational repression by 
selectively removing the transcripts from the translational pool. Cytoplasmic mRNA 
turnover is an important characteristic feature for cellular physiology and is a key factor 
in gene expression. The cis-acting elements reside within the 5’ or 3’ UTR of the mRNA 
have potential roles in cytoplasmic mRNA turnover by the recruitment and placement of 
trans-acting factors (Moore, 2005). RNA interference (RNAi) is a potential RNA-
mediated gene silencing pathway that occurs post transcriptionally to regulate gene 
expression either through mRNA degradation or mRNA suppression from translation 
(Saurabh et al., 2014).       
 
1.10 Discovery and general regulation of RNA interference (RNAi) pathways 
 
            RNA interference (RNAi) is an evolutionary conserved mechanism wherein small 
silencing RNAs play a vital role on their regulatory targets (mRNA) to reduce the 
expression of target genes (Ghildiyal and Zamore, 2009; Figure 1.3). Andrew Fire and 
Craig C. Mello were awarded the Nobel Prize in Physiology or Medicine in 2006 for 
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work on RNA interference in the nematode worm Caenorhabditis elegans, which was 
first published in 1998. In their study, it was discovered that double stranded RNA 
(dsRNA) has the ability to trigger RNAi (Fire et al., 1998). Among protozoan parasites, 
RNAi mechanisms were first discovered in Trypanosoma brucei (Ngo et al., 1998). From 
its discovery, RNAi and its regulatory roles was appreciated for its potential in 
suppression of gene expression and accepted as a precise, efficient, stable and improved 
technology for gene suppression analysis (Saurabh et al., 2014). MicroRNAs (miRNAs) 
and short interfering RNAs (siRNAs) are components of an RNA-based mechanism of 
gene regulation found in eukaryotes (Carthew, 2006; Ghildiyal and Zamore, 2009).  
            MiRNAs are endogenous small noncoding RNAs approximately 22 nucleotide 
long that derive from distinctive hairpin precursors in animals and plants and can play an 
important role in gene expression (Bartel, 2004; Wienholds et al., 2005). lin-4, is the first 
identified miRNA in C. elegans in 1993 which regulates post embryonic development  
(Lee et al., 1993; Wightman et al., 1993), and let-7, is the second discovered miRNA was 
also from the same worm (Reinhart et al., 2000). miRNAs are important for their vital 
role in multiple biological processes. miRNAs regulate gene expression by base-pairing 
to target gene mRNAs (Zhang et al., 2007). It has been suggested that around 30% to 
60% of mRNAs are regulated post-transcriptionally via miRNA (Friedman et al., 2009). 
Computational approaches and next generation sequencing provide a way to predict the 
miRNA targets which may provide the proper understanding of miRNA regulatory 
activities in different biological systems (Xu et al., 2014; Ekimler and Sahin., 2014).  
          During biogenesis, primary miRNAs (pri-miRNAs) are transcribed by RNA 
polymerase II (Pol II). The length of pri-miRNA varies from hundreds to thousands of 
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nucleotides (Cai et al., 2004; Lee et al., 2004). miRNAs can be transcribed from the 
introns of both protein coding and non-coding host genes (Lagos-Quintana et al., 2003). 
After synthesis, pri-miRNAs are bind with DGCR8/Pasha (a protein that contains two 
double-stranded RNA binding domains) through distinct stem-loop structures in the pri-
miRNAs. Drosha (a RNase III endonuclease) then cleaves the flanks of pri-miRNA to 
liberate a 60 to 70 nucleotide stem-loop to generate the precursor miRNA (pre-miRNA). 
The pre-miRNA contains a 5′phosphate and a 2 nucleotide 3′overhang (Gregory et al., 
2004; Denli et al., 2004; Han et al., 2004; Landthaler et al., 2004). miRNAs can also be 
produced from mirtrons (miRNAs found in introns) which are identical to pre-miRNAs. 
Mitrons are processed without Drosha (Ender and Meister, 2010), though they’re 
processed by the splicing machinery (Czech and Hannon, 2011). Following their 
biogenesis, pre-miRNAs are binds with the Exportin-5 in the presence of Ran-GTP 
cofactor and exports from the nucleus into the cytoplasm. (Yi et al.2003).   
          In the cytoplasm, the 2-nucleotide 3' overhang of pre-miRNAs is recognized by 
Dicer (a second RNase III endonuclease) for further processing. Dicer cleaves the hairpin 
structure and releases a 20-22 nucleotide length of double stranded miRNA, called the 
miRNA (guide strand):miRNA*(passenger strand) duplex (Grishok et al., 2001; 
Hutvagner et al., 2001; Ketting et al., 2001; Zhang et al., 2004). Finally, the duplex is 
unwound by ATP-dependent helicase into single stranded mature miRNA (guide strand) 
and a miRNA* (passenger strand). Passenger strand is degraded while guide strand is 
incorporated into a ribonucleoprotein effector RNA-induced silencing complex (RISC) 
which induces post-transcriptional gene silencing (Schwarz et al., 2003; Hammond, 
2005; Khvorova et al., 2003).  Mass spectrometric analyses revealed RISC components 
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in T. gondii which are similar to components characterized in human and Drosophila 
(Braun et al., 2010). In T. gondii, miRNAs are reported as highly dynamic translational 
regulators which regulate mRNA with perfect or near perfect complementary bindings 
(Braun et al., 2010) 
                           
 
 
Figure 1.3: The RNA interference pathway of gene silencing. MicroRNAs (miRNAs) are 
generally transcribed by RNA polymerase II and can also be produced from mirtrons. 
siRNAs are synthesized from long dsRNAs either from exogenous sources or 
endogenous sources. These miRNAs and siRNAs are incorporated into RNA-induced 
silencing complex (RISC) and induce post-transcriptional gene silencing (Ender and 
Meister, 2010).  
 
 
            SiRNAs are synthesized from long dsRNAs either from exogenous sources 
(exosiRNAs) or endogenous sources (endo-siRNAs; Ender and Meister, 2010; Ghildiyal 
and Zamore, 2009). Exogenous sources can be viral RNAs or artificially injected perfect 
base-paired dsRNA into the cytoplasm. The endogenous siRNAs can be derived from 
transposable elements, natural antisense transcripts, long inter-molecularly paired 
hairpins and pseudogenes. Endo-siRNAs have been found in plants and in animals such 
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as C. elegans, flies and mice. siRNAs are processed in a similar way to miRNAs, 
however siRNAs are processed by Dicer instead of Drosha (Ender and Meister, 2010). 
Afterwards, like miRNA processing, the guide strand of the siRNA duplex is 
incorporated into RNA-induced silencing complex (RISC) and induces post-
transcriptional gene silencing (Ghildiyal and Zamore, 2009; Iwasaki and Toomari, 2009; 
Ghildiyal and Zamore, 2009; Du and Zamore, 2005).       
 
          miRNAs recognize their targets through base pairing between the 5′ end of the 
miRNA (i.e. nucleotides 2–8, the seed region) and complementary sequences in the 
3′untranslated regions (3′ UTRs) of the target mRNAs and destabilized mRNAs. This is 
the major component of post transcriptional repression (Baek et al.2008; Timothy, 2007). 
In animal cells, an imperfect complementary sequence alignment between miRNA and its 
targeted mRNA can facilitate translational repression. The number of miRNA binding 
sites in a targeted mRNA often associates with the level of repression (Cuellar and 
McManus, 2005). Moreover, miRNA activity may diversify in a cell type–specific 
manner by RNA editing of a miRNA primary transcript. The middle of the 5’ proximal 
half “seed” region is the most important site for miRNA hybridization to targets 
(Kawahara et al., 2007). The mode of miRNA mediated gene regulation depends on the 
characteristics of the target recognition by miRNAs. The regulatory mechanism include, 
1) degradation of mRNA by sequence specific cleavage 2) inhibition of translation 
without sequence-specific mRNA degradation which includes inhibition of translational 
initiation, inhibition of translation elongation or premature termination of translation 
(ribosome drop-off), 3) mRNA de-adenylation and degradation, and/or 4) mRNA 
sequestration (Eulalio et al., 2008; Timothy, 2007; Engels and Hutvagner, 2006).     
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1.11 Argonaute protein 
 
            Argonaute protein is the central component of the RNA-induced silencing 
complex (RISC; Rand et al., 2004; Hutvagner and Simard, 2008). Argonaute proteins 
bind microRNAs (miRNAs) and small interfering RNAs (siRNAs), which directs 
argonaute protein to their specific targets through sequence complementarity and regulate 
specific gene expression (Rand et al., 2004; Song et al., 2004; Meister, 2013; Garcia-
Ruiz et al., 2015).    
 
1.12 Structure of the argonaute protein  
                         
 
 
Figure 1.4: Illustration of argonaute. Major domains and their core functions are shown 
(Ender and Meister, 2010) 
           
            The argonaute (AGO) protein has four characteristic domains: N- terminal, PAZ, 
Mid and a C-terminal PIWI domain (Hutvagner and Simard, 2008; Figure 1.4). The PAZ 
domain recognizes the characteristic 3’ overhang of both miRNAs and siRNAs by a low 
affinity sequence-independent manner (Lingel et al., 2004; Ma et al., 2004). The Mid 
domain anchors the 5′-phosphate of the siRNA and miRNA (Ma et al., 2005). Argonaute 
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protein from human, mammals, chordates (such as zebra-fish), Drosophila (AGO1), C. 
elegans (ALG-1 and ALG-2) contains the MC domain in the Mid domain, which 
encompasses significant similarity to the m7G cap binding motif of eIF4E, the translation 
initiation factor (Kiriakidou et al., 2007).   
            The PIWI domain exhibits the RNase-H-like fold (Asp-Asp-Glu/Asp) with the 
same cleavage activity (Song et al., 2004). Additionally, cleavage component of 
argonaute have a more relaxed catalytic centre (Asp-Asp-Asp/Glu/His/Lys), where two 
aspartates are very crucial to convey cleavage activity (Hutvagner and Simard, 2008). 
However, the PIWI domain of TgAgo lacked the canonical catalytic centre but R-R-E 
(Arg-Arg-Glu) residues may be responsible for weaker cleavage activity in TgAgo 
(Musiyenko et al., 2012). The most characteristic feature of the cleavage products from 
PIWI domain is that it contains a 3’OH group and 5’ phosphate which are also similar to 
the products of RNase-H-like processing. Furthermore, structural studies revealed that the 
small RNA-mediated cleavage of the target RNA always occurs at a fixed place (Yuan et 
al., 2005). Cleavage occurs between the tenth and eleventh nucleotides of the guide 
strand (counting from the anchored 5′-end) which precedes the scissile phosphate on the 
target RNA (Haley and Zamore, 2004). Some organisms may lack the PAZ domain and 
have only the PIWI domain for argonaute protein, for instance, Trypanosoma cruzi and 
Leishmania major, where these argonaut proteins are unnecessary for RNAi pathway 
(Hutvagner  and Simard, 2008).   
 
 
 
23 
 
1.13 Argonaute protein family 
            Argonaute proteins are categorized into three paralogous groups: 1) argonaute-
like proteins similar to Arabidopsis thaliana AGO1; 2) PIWI-like proteins, closely related 
to D. melanogaster PIWI; and the newly recognized, C. elegans-specific group 3 
argonautes (Yigit et al., 2006; Hutvagner and Simard, 2008). Argonaute-like and PIWI-
like proteins are found in eukaryotes, but the number of genes for argonaute varies in 
different species (Hutvagner and Simard, 2008). The human genome encodes for 8 
argonaute genes where 4 are argonaute-like and 4 are PIWI-like. Similarly, D. 
melanogaster encodes 5 argonaute genes (2 argonaute-like and 3 PIWI-like). On the 
other hand, A. thaliana has 10 and Schizosaccharomyces pombe has 1 argonaute 
encoding genes but all are argonaute like. C. elegans has about 26 argonaute genes where 
18 of them are group 3 argonautes but 5 are argonaute like and 3 are PIWI-like 
argonautes. However, organisms with both argonaute-like and PIWI-like paralogs, 
regulate two types of function. For example, PIWI-like proteins are related to 
transcriptional silencing such as transposon silencing in the nucleus, whereas argonaute-
like proteins are responsible for post transcriptional gene silencing mechanisms in the 
cytoplasm (Hutvagner and Simard, 2008).  
 
1.14 Argonaute function 
            Argonaute proteins (either argonaute-like or PIWI-like) are essential for RISC in 
small non-coding RNA-mediated silencing pathways in fission yeast, fungi, plants, flies 
and mammals (Irvine et al., 2006; Hutvagner and Simard, 2008). Argonaute-like protein 
(Ago2) in Drosophila and mammals contribute to siRNA maturation by removing the 
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non-active passenger strand and initiating sequence specific cleavage of the target RNAs 
(Matranga et al., 2005). PIWI-like proteins, by contrast, may participate in the maturation 
of repeat-associated small interfering (rasi) RNAs and Piwi-interacting RNAs (piRNAs) 
in flies and mammals (Gunawardane et al., 2007; Brennecke et al., 2007). However, 
some argonaute proteins, for instance human argonaute‑3 (AGO3), are not able to 
facilitate miRNA related cleavage of target RNA, though they have the intact PIWI 
domain with canonical active site. This suggests that not only the active PIWI domain but 
also other factors yet to be discovered may be necessary for cleavage activity of 
argonaute proteins (Hutvagner and Simard, 2008). Besides this, argonaute proteins are 
associated with developmental process in diverse organisms (Carmell et al., 2002). The 
reduction of argonaute expression in Drosophila and C. elegans produces defective 
germlines (Cox et al., 2000; Tijsterman et al., 2002).   
 
1.15 Argonaute protein in T. gondii 
          The argonaute protein of T. gondii can be categorized into Ago-like subfamilies 
because its similarity to Arabidopsis Ago1 (Al Riyahi et al., 2006). The T. gondii 
argonaute sequence shows greater similarity with Arabidopsis Ago1 than Drosophila 
PIWI.  T. gondii argonaute protein called TgAgo is approximately 58.5 kDa, encoding 
524 amino acids (GenBank accession no. DQ196314). This is smaller than argonaute 
proteins reported from other eukaryotic organisms but similar in size to argonaute from 
archaea. Amino acid sequence analysis revealed that TgAgo contains a conserved PIWI 
domain but lacks PAZ domain. Despite its small size, TgAgo is recruited into the RISC 
or effector complexes for gene silencing. However, other research groups have reported 
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different lengths of the argonaute protein including 743 aa (GenBank accession no. 
DQ177874), and 946 aa (GenBank accession no. GU046561).  
 
 1.16 T. gondii argonaute (TgAgo) sequence analysis 
            According to the ToxoDB.org (ToxoDB 31 9 Mar 17), gene TGGT1_310160 
(GT1), TGME49_310160 (ME49), and TGVEG_310160 (VEG) encode argonaute 
protein in T. gondii in three archetype strains, type 1 (GT1), type 2 (ME49), and type 3 
(VEG), respectively. The gene is located on chromosome XI, and the primary transcript 
(pre-mRNA) is predicted to have seven exons and six introns with 5346 nucleotides total. 
The mature transcript is predicted to contain 2841 nucleotides (exon 1: 372 + exon 2: 204 
+ exon 3: 267 + exon 4: 258 + exon 5: 150 + exon 6: 625 + exon 7: 965 nucleotides) and 
encodes 946 amino acid residues resulting in a predicted molecular weight of the 
argonaute protein of ~ 105 kDa.   
            However, the National Center for Biotechnology Information (NCBI) database 
(www.ncbi.nlm.nih.gov) has documented three different lengths of the T. gondii 
argonaute protein reported from three different research groups. The Hakimi research 
group (marked as number 1 in Figure 1.5) reported that argonaute consists of 946 amino 
acids (GenBank accession no. GU046561) and contains all 7 exons with a predicted 
polypeptide molecular weight of ~105 kDa as reported in ToxoDB.org (Braun et al., 
2010). The Barik research group (marked as number 2 in Figure 1.5) reported the size of 
argonaute consists of 743 amino acids (GenBank accession no. DQ177874), where the 
primary transcript (exons + introns) contains 3940 nucleotides and the mature transcript 
is 2232 nucleotides long and comprises 5 exons (Figure 1.5), with a calculated molecular 
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weight of 83.5 kDa. This latter author did not mention its molecular weight in any 
literature. The Ananvoranich research group (marked as number 3 in Figure 1.5) reported 
the expression of a short version of argonaute consisting of 524 amino acids (GenBank 
accession no. DQ196314). Where the pre-mRNA sequence is 2564 nucleotides and 
protein coding sequence is 1575 nucleotides with only 2 exons (Figure 1.5). In addition, 
this report indicated the 5’UTR (368 bp) and 3’ UTR (621 bp) and found the predicted 
molecular weight of argonaute to be 58.5 kDa (Al Riyahi et al., 2006). Notably, all 
research groups reported the same sequences at the 3’ end of the transcript but their 
observations vary at the 5’ end (Figure 1.5). Moreover, the predicted FASTA amino acid 
sequences also revealed that they vary from N- terminal end but C- terminal end have 
similar sequences for the functional domains of the active protein (Figure 1.6). It is 
possible that the argonaute protein encoding gene has more than one gene product at the 
protein level, which may be a result of an alternative splicing mechanism of mRNA from 
argonaute encoding gene.   
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Reported lengths of argonaute protein from T.  gondii  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 1.5: Different lengths of argonaute protein from T. gondii was documented in 
National Center for Biotechnology Information (NCBI). +1, indicate the first nucleotide 
of ORF for argonaute mentioned from different research groups. The largest reported 
length consists of 7 exons (CDS marked as 1) but another described size does not include 
exon 1 and 2 (CDS marked as 2). The smallest size reported has only exon 6 and 7, 
though the UTR’s were indicated (CDS marked as 3). CDS: Coding sequences.   
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FASTA format of amino acid sequences for argonaute protein from T.  gondii 
 
MNGGGRGRDGSRGRGGDSRAGSNPYGRGFGSGDHRGGNRGGGGPFGGGGRGGMG 
GGGFGSVLPVLRGPLKCLSNHCELVVSNRRQAVAVWKHFVDFKARAEPGKKRMLSYE 
ARREILDEFLDGLVALGHLARDERALILYDGDHLLVCMKKLEYIEMLRGVSLSIHPQQS 
VIMANLGEQLSMQNSATEEVAQILQLIMNHAAVMEGYQMFHGVNFFKDMPENFVPL 
RGPNKAFQIWDGFSQAVAPYQTAGTMSWNAVFNLRACTSTKAIPLVKYIEIQASAIAKR 
MVDLSTEKGCRALMADAEVMRRLNRRLRGTKLESFHILNRDTQQPEKRVYKLKELM 
TFSASSEESRFDLQDGRRVTVLQHFKETYPHASGIPPFQPLINTRSKDRPAYLPVSIVTL 
KHQPAREGVTEEDRAQVAEHMIMPPRNRVAKTEQLLSLVFGPQGHSAPKVLDAFGVIL 
QLEAKTAQGRVLESPLIKYREVPGGGPGRSSKTVRPAQGDWNLRDAAFCRGTVCKVW 
ALYSFVETSQNVIENLARVLKTQGAKYGVNLTTKPGLGAYTRNDRRPMLDQFAAFVAL 
AKTKGCELLFVILNERVSLDIYQIVKSCTDVNFPSQCLNGRHKCIDAIFRGADNPNPQYF 
ANVMSKVNMKLQGVNQTLEADIIKQEIGTDKSTLVLAVETSFFANPTKTSPPPTAPIVC 
ACTGNMDDDLGAFGHAVCVESRKHPIVTDIGSMFKTILSYRKTTKNWPARIIYLRSAT 
TEAHFPLVLAGEIRAIEELYVRENRSKPRILAVAVQRRQQTRLFPTKEMQAQGNNLPPG 
FLLANSLQHPGHFRNFLLISHKALQGTARPTRYYILRDDANRDMEKVAQLMYSLCHVY 
GRCQRAVSIPAPLYYAELLAARAQSYMKVGMRRERNIDIDDLSHLSGEAGEKMLTETR 
HFADEYLRSTAAKVTPMVFC  
 
Figure 1.6: FASTA format of amino acid sequences for argonaute protein from T. 
gondii. Orange square indicating start codon (M= Methionine) for different lab. Light 
green highlighted sequences indicates PAZ domain, reported in 2 labs (indicated 1 and 2 
in Figure 1.5). Violet color sequences PIWI + MID domain for argonaute reported from 
all labs.   
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1.17 Research goals and hypothesis 
 
            The current study was aimed to elucidate if variants of the argonaute protein are 
expressed by T. gondii. Argonaute cDNA was analyzed to determine the argonaute 
transcript variants. Protein immunoblot analysis was performed to determine the variants 
of the argonaute protein. C-terminal FLAG tagged stable transgenic parasites (pAGO-SF-
TAP-LIC-HX) were generated via a genetic approach called homologous recombination, 
where TgAGO was expressed with a FLAG under the control of its own promoter and 
thus expressed at the similar level as its parental strain.  
 
            The second objective of the study was to determine the contribution of argonaute 
protein to post transcriptional gene silencing in T. gondii, as well as to determine the 
value of argonaute proteins on the parasite growth and on interconversion ability. This 
aspect was performed by comparing the properties of wild type T. gondii stains with an 
argonaute knock-out (AGOKO) parasite strain.    
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Chapter 2 
Materials and Methods 
 
 
2.1 Cell and Parasite Culture  
2.1.1 Mammalian cell culture 
            Human foreskin fibroblasts (HFF, ATCC-1041) were used to maintain 
intracellular T. gondii. The HFF host cells were grown and maintained in Dulbecco’s 
Modified Eagle Medium (DMEM) with high D-glucose and L-glutamine (Invitrogen, 
#12100046) supplemented with 10% cosmic calf serum (ThermoFisher Scientific, 
Hylcone, # H3008704N), and 5μg/ml antibiotic-antimycotic (Invitrogen, # 15240-062) at 
37°C in 5% CO2.  
 
2.1.2 T. gondii culture 
            Confluent monolayers of HFF host cells were infected with T. gondii and 
sustained using Minimum Essential Medium (MEM, Invitrogen, #61100061) 
supplemented with 1% (v/v) dialyzed fetal bovine serum (dFBS) ((ThermoFisher 
Scientific, Hyclone, #SH3007903) and 5μg/ml antibiotic-antimycotic (Invitrogen, # 
15240-062) incubated at 37°C in 5% CO2.  
            RHΔHX is a T. gondii type 1 strain commonly used in laboratories which lacks 
the gene HXGPRT (Donald et al., 1996). RHΔHX was acquired from NIH AIDS 
Research and Reference Reagent Program (#2857). ΔKu80 strain (lacking the Ku80 
gene) is a RHΔHX-derived strain and was obtained from Dr. Vern B. Carruthers 
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(University of Michigan, USA). A null-TgAgo mutant (AGOKO) strain, also a RHΔHX-
derived strain, was obtained from Dr. Boothroyd, Stanford University School of 
Medicine. These strains were maintained in the culture media without selection. 
However, TgAgo-SF-TAP-LIC-HX transgenic parasites were generated by 
electroporation of ΔKu80ΔHX strain with plasmid (pAGO-SF-TAP-LIC-HX) containing 
HXGPRT and maintained in the culture media containing 25 μg/ml mycophenolic acid 
and 50 μg/ml xanthine.  
 
2.2 Plasmid generation  
2.2.1 Plasmid construction 
            pAGO-SF-TAP-LIC-HX plasmids were previously constructed using pSF-TAP-
LIC-HX plasmid (obtained from Dr. Vern B. Carruthers, University of Michigan). The 
coding sequences of TgAgo (Gene ID TGGT1_310160) were PCR amplified from the 
ΔKu80 parasite’s genome using the oligonucleotide primers. The construct was analyzed 
by restriction endonucleases.   
2.2.2 Transformation  
             Plasmids were transformed into DH5α competent bacterial cells and plasmid was 
isolated and restriction digested with appropriate restriction enzymes to confirm the 
desired plasmid construct. Briefly, all plasmids were transformed into DH5α competent 
E. coli cells by the heat shock method. 25 μL of competent cells were incubated with 2 
μL of plasmid DNA on ice for 30 mins, followed by heat shock at 42°C for 45 seconds, 
and incubating on ice for another 2 min. Afterward, 500 μL of pre-warmed (Room 
temperature) SOC (Super Optimal Broth with catabolite-repression) media (2% (w/v) 
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bacto-tryptone, 0.5% (w/v) bacto-yeast extract, 0.05% (w/v) NaCl, 10 mM MgCl2, 2.5 
mM KCl and 20 mM glucose) was added to obtain maximal transformation efficiency of 
E. coli. The reaction was incubated at 37°C for 1 hour with 225 rpm agitation. The cells 
were then plated on an LB (Luria-Bertani) agar plates containing ampicillin (1% (w/v) 
bacto-tryptone, 0.5% (w/v) bacto-yeast, 1% (w/v) NaCl, 1.5% (w/v) bacto-agar and 50 
mg/L antibiotic) and grown at 37°C overnight. 
 
2.2.3 Plasmid isolation by miniprep 
            A single colony was picked from LB agar plate using a sterile toothpick and 
transferred into 3 mL of LB broth supplemented with ampicillin antibiotic and grown at 
37°C overnight with 225 rpm agitation. An aliquot of the culture (1.5 ml) was centrifuged 
at 12,000 rpm for 1 min and the pellet was re-suspended in 100 μL of re-suspension 
solution (50 mM glucose, 25mM Tris-HCl (pH 8.0), 10 mM EDTA). Afterwards, the 
bacterial cells were lysed using 200 μL of lysis buffer solution (0.2N NaOH, and 1% 
SDS). Next, 150 μL of  precipitation buffer solution (3 M NaOAc, pH 5.2) was then 
added, the sample was mixed by inversion and centrifuged at 12,000 rpm for 15 min at 
4º C. The clear supernatant was transferred into new tube and combined with 400 μL of 
TE-buffered phenol:chloroform, vortexed for 30 seconds, and centrifuged at 12,000 rpm 
for 1 min at room temperature. The top aqueous phase was transferred into a fresh tube 
and the plasmid DNA was precipitated with 800 μL of 95% ethanol and centrifuged at 
12,000 rpm for 15 min at 4°C. The pellet was washed with 75% ethanol, air dried, re-
suspended in 30 μL of TE buffer containing 20 μg/ml RNase A and incubated at 37°C for 
15 min. The plasmid was stored at -20°C.  
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2.2.4 Restriction digestion   
            Plasmids were confirmed by restriction digestion (according to manufacturer’s 
protocol) with the appropriate restriction enzymes for a minimum of 2 hours at 37°C. The 
restriction fragments were resolved on 1% (w/v) agarose gels (0.4 g agarose in 40 mL of 
1x TAE buffer, and 0.02% (w/v) ethidium bromide). The samples were mixed with DNA 
gel loading Dye (6x: 0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene cyanol FF, and 
40% (w/v) sucrose in water) .The gel was electrophoresed for 25 mins at 140 V in the 
miniature horizontal gel system with 1x TAE buffer. Gels were visualized and imaged 
using an Alpha imager Imaging System.  
 
2.3 Transfection of plasmid in T. gondii by electroporation  
            Freshly lysed ΔKu80 parasites (~ 2 x 106 parasites) were collected and 
centrifuged at 5000 rpm for 5 minutes and the pellet was resuspended with 400 μL 
electroporation mixture (cytomix) buffer (120 mM KCl, 0.15 mM CaCl2, 10 mM 
K2HPO4/KH2PO4 (pH 7.6), 2 mM EDTA, 5 mM MgCl2, 2 mM ATP, 5 mM 
glutathione), 2 mM ATP and 5 mM glutathione were added to the mixture prior to 
electroporation (Roos et al., 1995). Ago-SF-TAP-LIC-HX plasmids were digested with 
AflII restriction enzyme to linearize the plasmid and 50 μg of linearized plasmids were 
added to the mixture and transferred to 4 mm-gap cuvette. The instrument used for 
electroporation was BTX ECM 630 (Voltage: 1500, Resistance: 25 Ω, Capacitance: 25 
μF). Immediately after electroporation, the parasites were cultured in confluent HFF 
monolayers at 37°C in 5% CO2 using MEM with 1% dialyzed fetal bovine serum (dFBS) 
and antibiotic-antimycotic. 24 hours post infection, the media was replaced with MEM 
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supplemented with 1% dFBS, 0.5x antibiotic antimycotic, 25 μg/ml mycophenolic acid 
and 50 μg/ml xanthine to select the transgenic parasites.   
            Parasites which integrate the plasmid in their genome (stable transgenic parasites) 
were isolated according to the protocol from Rommereim et al., 2013. Freshly lysed 
parasites were counted using a haemocytometer and was infected the HFF confluent cells 
with 1 parasite per 200 μL of culturing media in each well of 96-well plates by serial 
dilution. The wells were then incubated at 37°C in 5% CO2 for 5 to 6 days and were 
observed under microscope for 5 to 6 days for the well contains a single parasitophorous 
vacuole. When the parasites lysed out, they were sub-cultured to 6 well plates. The 
transgenic parasites were then confirmed by western blotting analysis.  
 
2.4 Western blotting  
            Western blot analyses were performed using the lysates prepared from freshly 
lysed parasites. Freshly lysed parasites were pelleted by centrifugation at 500 rpm for 5 
minutes and resuspended in 40 μL 1x TE buffer containing 1 mM phenylmethylsulfonyl 
fluoride (PMSF) and aprotinin (protease inhibitor; 1 μg/mL). The mixture was then 
sonicated for 1 min, kept on ice and centrifuged at 13,000 rpm for 1 min at room 
temperature. The supernatant was separated from the cellular debris and protein 
concentration measured using the Bradford reagent according to manufacturer’s 
instructions. Absorbance was measured at 595 nm on the Genesys 10 UV/Visible 
spectrophotometer.  
            Cell lysates were denatured in 6x SDS protein loading dye (12% (w/v) SDS, 
0.06% (w/v) bromophenol blue, 47% (v/v) glycerol, 6% (v/v) 1M Tris-pH 6.8 and 12.5% 
(v/v) β mercaptoethanol). This mixture was then heated for 15 minutes and resolved on a 
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10% SDS-PAGE at 140 V for 1 h 30 mins in a 1x SDS-PAGE running buffer (25 mM 
Tris-base (pH 8.3), 250 mM glycine, and 0.1% SDS) using a vertical gel electrophoresis 
system, and subsequently transferred to a nitrocellulose membrane at 100 V for 1 h in 1x 
transfer buffer (20% (v/v) methanol, 0.29% (w/v) glycine, 0.59% (w/v) Tris-base, 
0.037% SDS). After transfer, the membrane was blocked in 5% (w/v) non-fat milk in 1x 
Tris-buffered saline containing Tween-20 (TBST; 0.068 M NaCl, 8.3 mM Tris-base (pH 
7.6), 0.1% Tween) for 1 h at 4°C temperature. Blocked membranes were then probed 
with the rabbit anti-FLAG (1:5,000) (Frogga) primary antibodies in 2% (w/v) non-fat 
milk in TBST overnight at 4°C. The membrane was washed 3 times for 5 min with 
1xTBST at room temperature. Afterwards, the membrane was incubated in horseradish 
peroxidase-conjugated goat anti-rabbit (1:20,000) secondary antibody for 1 hr at room 
temperature, and washed again 3 times for 5 min each.  Chemiluminescent detection was 
performed using the chemiluminescent HRP substrate kit (Millipore, #WBKLS0500) and 
visualized using the FluorChem Q Imager (Alpha Innotech) with AlphaView-FluorChem 
Q software.  
 
2.5 Genomic DNA isolation 
            Genomic DNA was isolated using DNAzol Reagent (Molecular Research Center, 
Inc) per manufacturer’s instructions. After collection of egressed parasites from culture 
plates, parasites were pelleted at 5000 rpm for 5 mins and re-suspended in 100 μL of 
distilled H2O mixed with 100 μL of DNAzol Reagent and lysed by gentle pipetting. 200 
μL of phenol chloroform was subsequently added to the tube and centrifuged for 1 min at 
12,000 rpm at room temperature. The supernatant was then transferred to a fresh tube. 
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DNA was precipitated by the addition of 20 μL of 3M NaOAc (pH 5.2) and 800 μL of 
cold 95% ethanol and mixed by inversion. The mixture then incubated at -80°C for 15 
mins, followed by centrifugation at 12,000 rpm for 15 mins at 4°C to pellet the DNA. 
The DNA precipitate was washed with 500 μL of 75% ethanol, air dried for 15 mins, and 
resuspended in 30 μL of TE buffer containing RNase A (20 µg/ml) and the tube 
incubated for 15 minutes at 37°C. Finally, the genomic DNA was stored at   -20°C. 
 
2.6 RNA isolation 
            Total RNA was isolated from freshly egressed RH∆HX parasites using the TRI 
reagent (Molecular Research Center, Inc., # TR 118). Parasites were centrifuged at 5000 
rpm for 5 mins and the parasite pellets were re-suspended in 500 μL of TRIzol reagent 
for homogenization. Homogenized sample then incubated for 5 minutes at room 
temperature to allow complete dissociation of nucleoprotein complex. Afterwards, 100 
μL of phenol chloroform was added and mixed by inversion. The mixture was incubated 
for 2-3 minutes at room temperature, followed by centrifugation at 12,000 rpm for 15 min 
at 4°C and the aqueous supernatant transferred to a fresh tube.  After that, 500 μL of 
100% isopropanol was added to the aqueous phase and mixed by inversion for 
homogenization. The tube was incubated at room temperature for 10 minutes then 
centrifuged for 20 minutes at 12,000 rpm at 4°C. The supernatant was removed and the 
precipitated RNA was washed with 500 μL of 75% ethanol, air dried for 15 mins, and 
resuspended in 30 μL of DEPC-treated water. RNA was treated with 1 unit of RQ1 
RNase free DNase (Promega, #M6101) for 30 minutes at 37°C. Treated RNA samples 
were quantified by Nanodrop and then electrophoresed on 1 % agarose gel to verify for 
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the presence of distinct rRNAs and mRNA smear bands, and the absence of DNA 
templates. Samples were stored for further uses at −20°C. The RNA was used for reverse 
transcriptase reaction.    
 
2.7 Reverse transcription reaction (to produce cDNA) 
            The reverse transcriptase reaction was performed as per manufacturer’s 
instructions (M-MuLV Reverse transcriptase; BioBasic Inc). About 2 µg of total RNA 
were annealed with 250 ng of gene specific primer (TgArg3'end: 
5’GCTTCGCCACTGAGGTGAG3’). A negative control reaction excluding reverse 
transcriptase enzyme was also performed (NoRT). The extension temperature was 42°C 
for 1 hour.   
 
2.8 Polymerase chain reaction (PCR)  
 
            PCR was performed per the manufacturer’s protocol (Taq DNA polymerase). 
Reaction volume of 25 μL containing 2.5 μL (x10 concentration) of Taq DNA 
polymerase buffer, 1.25 μL of 50 mM MgCl2, 2 μL of 2.5 mM dNTPs, 1 μL of 10 μM 
primers (forward and reverse), 0.2 μL of Taq DNA polymerase enzyme, 1 μL template (1 
μg) and nuclease free dH2O volume to 25 μL mixed in a PCR tube. The PCR reaction 
tubes were placed in the 96-well BioRad T100TM Thermal Cycler for 30 cycles 
(Denaturation, Annealing, Extension/Elongation temperature and duration were fixed 
according to protocol and length of PCR product).  
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2.9 RNA interference assay (Dual Luciferase assay) 
            To do the gene silencing assay, a dual luciferase plasmid system was employed. 
The system consists of two plasmids referred to as Firefly luciferase (Ffluc) and Renilla 
luciferase (Rnluc) (Crater et al., 2012). To ensure the equal level of transcript production 
and stability of the transcript, the same promoter (TgTubulin) and same 3’UTR was used 
for construction of both of the plasmids (Crater et al., 2012). The Renilla plasmid 
contained the microRNA (miRNA) binding site whereas Firefly plasmid did not. Three 
different Rnluc plasmids were used where one does not exhibit binding site, another two 
Rnluc transcript carrying three binding sites (complementary nucleotide sequence to the 
guide strand) for one of two abundant endogenous Tg-miRNAs species, namely Tg-miR-
60a (pTubRnMIR-60a3x) and Tg-miR-4a (pTubRnMIR-4a3x). Following transfection by 
electroporation with equal concentrations (1µg) of luciferase plasmid Rnluc (pTubRn) 
and Ffluc (pTubFf)), the parasites were cultured in confluent HFF monolayers grown in 
60 mm tissue culture plates using using MEM media with 1% dFBS and antibiotic-
antimycotic at 37°C in 5% CO2. 48 hours post infection, the freshly egressed parasites 
were harvested, and lysed with 100 µL of 1x Passive Lysis Buffer (Promega, #E1531) 
and incubated at room temperature for 10 minutes. The clear supernatant was collected 
after brief centrifugation at 12,000 rpm for 2 mins and the supernatant was kept on ice 
and used for the dual luciferase assay. For a Ffluc assay, 100 μL of freshly prepared 
reaction mixture containing 200 μM D-luciferin (Sigma Aldrich, #L9504), 20 mM 
Tricine, 10 mM MgSO4, 5 mM DTT, 250 μM ATP and 250 μM Coenzyme A was mixed 
with  20 μL of lysate and was incubated for 10 seconds at room temperature. Similarly, 
for Rnluc assays, 100 μL of freshly prepared reaction mixture containing 0.1 μM 
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Coelenterazine (Santa Cruz Biotechnology Inc, #sc-205908), 100 mM K2HPO4/KH2PO4 
(pH 7.6) 500 mM NaCl, 1 mM EDTA, and 0.02% BSA was mixed with 20 μL of lysate 
and was incubated for 10 seconds at room temperature. Immediately after a10 second 
incubation, the luminescence signals from both reactions were measured with a 20/20n 
Luminometer (Turner Biosystems; Crater et al., 2012). Three independent experiments 
were performed. 
 
2.10 Growth rate assay  
            HFF cells were grown on coverslips until confluent. Coverslips with confluent 
host cell monolayers were infected with 20 μL of freshly lysed parasites and incubated at 
37°C in 5% CO2 with MEM media supplemented with L-glutamine and 1% fetal bovine 
serum (FBS) (Hyclone) and 0.5% antibiotic antimitotic (Invitrogen, # 15240-062). The 
parasites were allowed to infect the HFF on the cover-slips and the infected cells were 
grown for either 24 or 36 h for the determination of growth. The cover-slips were fixed 
with 3% paraformaldehyde and then Hoechst stained (concentration 3.25 μM). 
 
2.11 Bradyzoite differentiation assay (Alkaline treatment)  
            For bradyzoite differentiation assays, confluent HFF cells were grown on 
coverslips and infected with about 20 μL of freshly lysed parasite (tachyzoite form) and 
incubated at 37°C in 5% CO2 for 8 hours in MEM media supplemented with L-glutamine 
and 1% fetal bovine serum (FBS; Hyclone) and 0.5% antibiotic-antimycotic (Invitrogen, 
# 15240-062). MEM media was subsequently replaced with RPMI-1640 media 
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(Invitrogen) at pH 8.3, and incubated at 37°C without CO2 to induce bradyzoite 
formation. RPMI media was changed every 48 hours and for 5 days (Soete et al., 1994).  
2.12 Fluorescence microscopy  
            Coverslips containing T. gondii infected HFF cells were rinsed three times with 
1x Dulbecco's phosphate buffer saline (DPBS), fixed with 3% (w/v) paraformaldehyde 
for 5 minutes and permeabilized with 0.25% Triton X 100 in PBS for 10 minutes. 
Coverslips were then washed three times with 1x PBS and subsequently incubated in a 
blocking solution of 5% (w/v) bovine serum albumin (BSA) in PBS with gentle agitation 
for 1 hour at room temperature. Coverslips were then incubated in a humidified chamber 
with FITC conjugated Dolichos biflorus agglutinin (1:300) and diluted in 2% (w/v) BSA 
for 1 hour for the visualization of cyst structures. Cells were stained with 3.25 μM 
Hoechst stain (Sigma-Aldrich) for 10 mins at room temperature with gentle agitation. 
Afterwards, the coverslips were washed again 3 times with 1x PBS and mounted on glass 
slides with aqueous mounting medium (Fluoromount). Imaging was performed using a 
Leica DMI 6000 fluorescence microscope, with a Leica DFC 360FX camera and a Leica 
STP6000 control board. Fields of fluorescent cells were positioned at the 40X objective 
and images were obtained under the PL Apo 100x/1.40 oil objective and a 1.52 refraction 
index. The blue filter was used in the detection of Hoechst 33342, the green filter was 
used to detect green florescent cyst wall with Dolichos biflorus lectin stain utilizing Leica 
Application Software (LAS).   
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2.13 PCR cloning 
            PCR products (Result section; Fig 3.3 B7) were purified using a gel extraction 
technique (QIAEX, Cat. No. 20021) verified by gel electrophoresis and quantified by 
Nanodrop. pGEM-T Easy Vector (Promega) used for PCR cloning, according to 
manufacturer’s protocol. 50 ng of linearized vector and 6 ng of PCR products were added 
to the tube containing ligation buffer with T4 DNA Ligase. After mixing, the reactions 
were incubated overnight at 4°C. After ligation, the recombinant DNA molecules were 
then transformed into competent DH5α E. coli cells and cultured on LB-ampicillin-X-Gal 
plates for blue/white color screening. The white colonies (contain inserts) were picked 
and cultured in LB broth with ampicillin and plasmids isolated to verify by restriction 
digestion that the plasmid contained the insert. The verified plasmids were then subjected 
to DNA sequencing.     
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Chapter 3  
Results 
 
            The first section of results describes an investigation of the expression of 
argonaute protein in T. gondii. A stable transgenic parasite strain of C- terminal FLAG-
tagged argonaute was generated for the investigation. The second section highlights the 
functional contribution of the argonaute proteins to post-transcriptional gene silencing in 
T. gondii, as well as the influence of argonaute protein on parasite growth and 
interconversion. The latter study was performed using wild type T. gondii and argonaute 
knock-out (AGOKO) parasite strains.   
3.1 Investigation of the argonaute variants in T. gondii    
3.1.1 Analysis of argonaute transcripts from T. gondii.  
            cDNA coding for argonaute protein was obtained by reverse transcription of total 
RNA by M-MuLV reverse transcriptase, using argonaute gene specific primers 
(TgArg3'end and AGO Exon 5_Rv) as shown in Figure 3.1 A. TgArg3'end  primer binds 
to the transcript in exon 7 and amplified full length of cDNA to exon 1. And AGO Exon 
5_Rv primer used to further verify the 5’ end of the transcript which binds to the 
transcript in exon 5 and amplified to exon 1. To verify the quality of cDNA and to ensure 
the cDNA was not contaminated with genomic DNA, an end-point PCR was performed 
with a specific primer set (indicated as “a” in Figure 3.1 A) using cDNA sample and no-
RT control. A PCR product was observed from the cDNA sample (L1; Figure 3.1 B1) but 
not from negative control (L9; Figure 3.1 B1). Eight different overlapping primer sets 
(indicated as a, b, c, d, e, f, g, h) were then used to detect different regions of the 
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transcript (Figure 3.1 A). The PCR product from primer set “a” showed a single band at 
the predicted length of 860 bp (L1; Figure 3.1 B1), and no alternative band or form was 
observed from this region. Similarly, for primer set “b” the predicted product was 
detected (816 bp) but a very short product was also seen that not correlate with any length 
of alternative form of transcript (L2; Figure 3.1 B1). Primer set “c” amplified a single 
product which corresponding to the predicted length of 298 bp with no alternative band 
or form for this primer set (L3; Figure 3.1 B1). Primer set “d” and primer set “e” 
produced predicted PCR products indicated with one low intensity band suggesting the 
products were either derived from alternative form of transcript or from the different 
length of cDNA product amplified from same gene specific primer (TgArg3'end) or from 
the degraded cDNA product or primer non-specific attachment to the template (L4, L5; 
Figure 3.1 B1). To confirm these results an independent PCR analysis was conducted 
with the same primer sets (“d” and “e”) from different cDNA sample and even using 
different PCR reagent (L1 and L2; Figure 3.1 B2, L1; Figure 3.1 B3 and L1; Figure 3.1 
B6). PCR product from primer set “d” were also compared between the cDNA sample 
from TgArg3'end and AGO Exon 5_Rv gene specific primers (L1 and L2; Figure 3.1 
B2). PCR product from primer set “d” shown a prominent band at the predicted position 
(570 bp) (L1 and L2; Figure 3.1 B2 and L1; Figure 3.1 B6). On the other hand, primer set 
“e” which overlaps the region for primer set “c and d” amplified a single predicted length 
(738 bp) of PCR product (L1; Figure 3.1 B3) which strongly suggested that there was no 
alternative form of transcript for this region. Therefore , the primer sets “a”, “b”, “c”, “d” 
and “e” confirmed the length of the sequences from exon 3 to exon 7 with no alternative 
form of the transcript.  
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            Primer sets “f”, “g” and “h” were used to analyze the transcript from exon 1 to the 
5’ junction of exon 3 (L6, L7, L8; Figure 3.1 B1). Primer set “f” showed a shorter band 
(~500 bp) than the expected band of 869 bp (L6; Figure 3.1 B1) whereas primer set “g” 
showed a larger band (~500 bp) than the expected band of 393 bp (L7; Figure 3.1 B1). 
Even though, primer set “f” overlaps the region of primer set “g” (Figure 3.1 A), both 
primer sets produced similar size product. Noticeably, primer set “f” and “g” were used 
to amplify the product from genomic DNA to ensure the primer set is amplifying the 
predicted product from genomic DNA (L2, L1; Figure 3.1 B4). The lengths of the 
amplified PCR product were expected (L2, L1; Figure 3.1 B4).  Afterwards, Several PCR 
reactions were conducted for these primer sets using cDNA from TgArg3'end and AGO 
Exon 5_Rv to verify the data but only the unexpected length of PCR products were 
amplified (L3, L4, L5, L6; Figure 3.1 B2, L2 and L1; Figure 3.1 B5, L2; Figure 3.1 B6) 
which did not even correlates with any alternative form of the transcript. Finally, primer 
set “h” which overlaps the primer sets “f” and “g” region showed a shorter band (~600 
bp) than the expected size of 1179 bp (L8; Figure 3.1 B1, L7 and L8; Figure 3.1 B2). A 
new PCR was conducted using newly amplified cDNA sample with different brand end-
point PCR reagent to crosscheck if there were multiple bands which could indicate an 
alternative form of the transcript (L1; Figure 3.1 B7). Multiple bands were detected for 
the primer set “h” suggesting the variation in this region may correlate with alternative 
forms of argonaute mRNA. PCR products that appeared at around 1200, 900, 700 bp (L1; 
Figure 3.1 B7) were isolated for DNA cloning and sent for nucleotide sequencing. The 
sequences did not have T. gondii argonaute in them, but sequences showed similarity 
with sequences from T. gondii Zinc finger domain containing protein mRNA, 
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Wuchereria bancrofti genome, the T. gondii genome (VEG, chromosome III, V, VI, IX, 
XI), a T. gondii putative glycoprotein mRNA, the T. gondii Tubulin beta chain gene 
CDS, a Neospora caninum Liverpool hypothetical protein mRNA, a Neospora caninum 
Liverpool genome sequence (chromosome IX), a T gondii serine/ threonine protein 
kinase putative mRNA and a T. gondii hypothetical protein mRNA. However, a portion 
of the sequences from the transcript which was common to all the related CDS reported 
in different lab was amplified by PCR and also sent for sequencing, which showed the 
same sequence with T. gondii argonaute.  
 
3.1.2 Generation of transgenic T. gondii strains expressing recombinant tagged 
TgAgo protein at physiological levels 
            To determine if T. gondii expresses different variants of the argonaute protein, a 
streptavidin-FLAG (SF; 21 a.a., ~2.5 kDa) were tagged C-terminally to create TgAgo-SF 
strains via a homologous recombination (knock-in) in the ΔKu80∆HX parasite strain. The 
ΔKu80 strain allows for only homologous recombination (Huynh and Carruthers, 2009). 
PCR analysis was performed to isolate and identify parasite clones stably expressing SF, 
using primer set “a” and “b” (a+b; Figure: 3.2A1). To monitor the expression of 
recombinant protein, positive clones and parental strains were analyzed (western blot 
analysis) using α- FLAG antibody. Several western blot analyses were performed using 
protein isolated from different passage of the parasite (Figure: 3.2 B1-B4). When parasite 
lysates were analyzed with α-FLAG antibody a clear prominent band was observed at 
~62 kDa for FLAG tagged argonaute from all of the western blot membrane. No band 
was observed for parental strain (ΔKu80∆HX), which was used as a negative control 
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where argonaute was not tagged (Figure: 3.2 B1-B4).The molecular weight of the 
streptavidin FLAG (SF) TAP is ~2.5 kDa and the molecular weight corresponding to the 
argonaute protein itself is ~58.5 kDa. A band at ~23 kDa (Fig 3.2 B3) might be the 
degraded product.   
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Figure 3.1: Detection of argonaute transcripts from T. gondii. A) The full length of 
argonaute transcript (Exon 1 -7 and their length indicated) from Toxodb.org. The gene 
specific primers used for reverse transcriptase reaction as well as 8 overlapping primer 
sets indicated as a, b, c, d, e, f, g, h. B) PCR product ran on 1% agarose gel. In “B1” gel 
image shows all PCR products for 8 overlapping primer sets including the sample from 
negative reverse transcriptase reaction. In B2 gel image shows the PCR product using 
cDNA from TgArg3'end and AGO Exon 5_Rv gene specific primers, B4 shows the PCR 
product for primer set “a, f, g” from genomic DNA. B3, B5, B6 and B7 show the PCR 
product for primer set “d, e, f, g, h” after running a new PCR using different gene specific 
primers and also using differ PCR enzyme. Two different types of 1Kb ladder were used 
for the gel images where in B1 the lower band starts from 300 bp but for B2-B7 the lower 
band starts from 250 bp.    
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Figure 3.2: Investigation of the size of the argonaute protein from T. gondii. ΔKu80 
parasites were genetically modified to contain transgenic sequences allowing for the 
analysis of endogenous TgAgo protein. A) Illustration of parental and transgenic genomic 
arrangement B) Expression of TgAgo-SF in transgenic parasites. Western blot image 
shows the band for FLAG tagged argonaute protein from T. gondii and no band for wild 
type T. gondii (ΔKu80ΔHX) as negative control.  
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3.2 The contribution of argonaute protein to post-transcriptional gene silencing 
pathway in T. gondii, and effect on parasites growth and interconversion ability.   
3.2.1 Verification of argonaute gene knock out from T. gondii genome.  
            The AGOKO clonal strain was obtained from Dr. Boothroyd (Stanford University 
School of Medicine). The clonal strain was analysed to confirm that the argonaute 
encoding sequence was replaced by the targeted plasmid insertion. Three primer sets 
(Figure 3.3) were used in end-point PCR analysis to evaluate for the replacement of the 
argonaute gene by the Hypoxanthine-Xanthine guanine phosphoribosyltransferase 
(HXGPRT) cassette. The primer set c+c’ corresponded to the deleted region, where a 
PCR product was not observed from AGOKO strain but was observed from the parental 
strain, thus identifying argonaute knock out clones (Figure 3.3). Furthermore, PCR using 
primer sets a+a’ and b+b’, which corresponded to the inserted region, were positive from 
argonaute disrupted clones (AGOKO), but were negative in RH∆HX strain. These results 
suggested that the HXGPRT cassette was inserted correctly into the argonaute locus 
(Figure 3.3).   
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Figure 3.3: Confirmation of argonaute gene knocked out from T. gondii genome. A) 
Plasmid constructs for AGOKO (see appendix to see actual plasmid contruct) from T. 
gondii genome. Plasmid targets a 5.3 kb deletion of the argonaute gene via integration 
of the HXGPRT cassette (backward orientation) into the RH∆HX strain. B) Primer 
sets were used to evaluate the parentral strain (RH∆HX) and AGOKO for 
replacement of the argonaute gene with HX cassette. (Designated PCR product were 
indicated with asteric* mark) 
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3.2.2 Gene silencing assay analysis using reporter silencing assay (Dual Luciferase 
assay). 
            Since argonaute proteins are the core component in the RNA interference (RNAi) 
gene silencing pathway (Rand et al., 2004; Song et al., 2004), the removal of the lone 
argonaute encoding gene should alter post transcriptional gene regulation in T. gondii. 
This hypothesis was tested by comparing the gene silencing ability of the argonaute 
knockout strain (AGOKO) with the wild type parasite (RH∆HX). A dual luciferase 
reporter system was used to evaluate this hypothesis. In the dual luciferase assay, two 
reporter transcripts were used, namely Firefly luciferase (Ffluc) and Renilla luciferase 
(Rnluc) (Figure 3.4 A). Ffluc transcript lacking a microRNA binding site and was used 
for internal control for transfection efficiency among various experiments. On a parental 
construct of an Rnluc transcript carrying the Tg-miRNA binding sites (complementary 
nucleotide sequence to the guide strand) for one of two abundant endogenous Tg-
miRNAs species, namely Tg-miR-60a and Tg-miR-4a. The Rnluc transcript with the Tg-
miR-60a binding site was indicated as Rn60a and Rn4a with Tg-miR-4a binding site. The 
guide strands (25-26 nucleotides) and seed sequences (underlined 6 nucleotides) of Tg-
miR-60a and Tg-miR-4a are shown in Figure 3.4 B. The relative expression of the Rnluc 
transcripts with Tg-miRNAs binding site was measured and normalized against the Rnluc 
reporter transcript without any binding sites for Tg-miRNAs (Rnob). RH∆HX revealed 
that transcripts with the Tg-miR-60a binding site showed a relative expression of 28 ± 
23%, reflecting a silencing effect of 72% whereas the transcript with a Tg-miR-4a 
binding site showed a relative expression to 55 ± 16%, reflecting a 45% silencing effect, 
which is in agreement with previous studies (Crater et al., 2015). On the other hand, in 
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AGOKO parasites, transcripts with Tg-miR-60a binding site showed a relative expression 
of around 98 ± 4%, reflecting only a 2% silencing effect. The transcript with Tg-miR-4a 
binding site showed a relative expression of around 86 ± 15%, reflecting a silencing 
effect of 14%. In conclusion, it was found that the silencing ability of the parasites was 
reduced for both Tg-miR60a and for Tg-miR-4a targets in the absence of argonaute 
expression (Figure 3.4 C).  
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Figure 3.4: Gene silencing assay. A) Graphical representation of transcripts generated 
from the dual luciferase reporter system used in this study. Asterisk (*) mark on Renilla 
luciferase (Rnluc) transcript indicates the microRNA binding site. Firefly transcript does 
not contain microRNA binding site. B) Tg-mir60a and Tg-mir4a binding sequences. The 
guide strands (25-26 nucleotides) and seed sequences (underline marked) of Tg-miR-60a 
and Tg-miR-4a are shown. Three different Renilla constructs were used, where one has 
no binding site (Rnob), another one has binding site for Tg-miR-60a (Rn60a) and the 
third one has for Tg-miR-4a (Rn4a).  C) Dual Luciferase assay for RH∆HX and AGOKO. 
Relative Renilla expression was normalized against Renilla with no binding site (Rnob) 
expression. Concentration used for electroporation: Ffluc: Rnluc = 1:1; 1 µg of each 
construct. Analyses were performed in triplicate with standard deviation shown (error 
bars).   
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3.2.3 The role of argonaute on growth rate and bradyzoite differentiation in T. 
gondii. 
3.2.3.1 Growth rate assay:  
 
            The study was design to determine if the ablation of argonaute expression has any 
effect on parasite growth. To assess growth, parasite numbers per vacuole were counted 
after 24 hours and 36 hours following infection (Figure 3.5 A). After 24 hours of 
infection, 40 ± 6% of vacuoles showed 8 parasites per vacuole for the RH∆HX strains, 
but AGOKO parasites exhibited 46 ± 5%. Furthermore, the number of vacuoles with 16 
parasites/vacuole from RH∆HX and AGOKO was 40 ± 0% and 36 ± 3% respectively 
(Figure 3.5 B). This gives an average parasite doubling time of approximately 6-8 hours 
for both strains. Around 16% of the vacuoles contained 4 parasites and a relatively few 
number of vacuoles contained 2 parasites per vacuole for both RH∆HX and AGOKO 
strains. After 36 hours of infection, RH∆HX showed 29 ± 1% of vacuoles contained 16 
parasites per vacuole and 26 ± 3% in AGOKO. In addition, 64% of vacuoles in RH∆HX 
and 68% of vacuoles in AGOKO were found to contain 32 parasites per vacuole (Figure 
3.5 C). These figures were correlated with a doubling time of 6-8 hour for both RH∆HX 
and AGOKO strians. In summary, this study revealed that altered argonaute expression 
did not significantly affect parasitic growth.  
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Figure 3.5: Growth analysis of AGOKO transgenic and parental clones at 24 and 36 
hours.  A) The nuclei were stained with Hoechst. The thick arrow indicates the nucleus of 
the HFF host cell, while the thin arrow indicates the nuclei of the T. gondii parasites in a 
vacuole. A1 shows 16 parasites in a vacuole and A2 shows 32 parasites in a vacuole. 
Parental (RHΔHX) and transgenic strains were allowed to infect HFF monolayers and the 
numbers of parasites were counted per vacuole 24 and 36 hrs post-infection (B and C). At 
24 hours, vacuoles for both parental and transgenic clones were found to contain 8 and 16 
parasites (B). At 36 hours post-infection, the majority of vacuoles contained 32 parasites 
(C). Analyses were performed in triplicate with standard deviation shown (error bars). 
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3.2.3.2 The role of argonaute  in bradyzoite differentiation  
            A database (ToxoDB.org) search for T. gondii argonaute revealed that the 
interconversion ability was less in Type 1 parasites (RH) then type 2 (ME49), but that the 
expression of argonaute was higher in type 1 parasite compared to type 2. The 
information suggested that the level of argonaute expression may affect the ability of the 
parasite to differentiate into bradyzoites.  This hypothesis was assessed by comparing the 
differentiation ability of AGOKO and wild type parasite strains (RH∆HX) under alkaline 
growth conditions. Cyst formation was quantified by counting the number of vacuoles 
that formed cysts under tested condition in both strains (Figure 3.6a). Percentages of 
vacuoles that formed cysts were ~25% from RH∆HX and ~62% from AGOKO, which 
supports the hypothesis that argonaute expression is correlated with bradyzoite 
differentiation capacity (Figure 3.6b).   
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Figure 3.6: a) Differentiation assay of transgenic AGOKO parasites in 
comparison to parental parasites (RH∆HX).  Parasites were cultured for 5 days 
(120 hrs) under alkaline condition (pH 8.3). Dolichos biflorus- FITC stain was 
used to reveal cyst structure, and Hoechst staining to visualize the nuclei. Image 
shows the Cyst structure after Dolichos-FITC by AGOKO parasites (A3). b) 
Quantification of cyst formation in AGOKO parasites compare to parental 
parasites (RH∆HX). Single analyses were performed.  
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 Chapter 4 
Discussion and conclusion 
 
            RNA interference (RNAi) is a naturally occurring, evolutionary conserved, highly 
efficient post transcriptional gene regulation pathway. Many components of the RNAi 
were discovered in T. gondii, two of which are miRNAs and the argonaute protein (Al 
Riyahi et al., 2006; Braun et al., 2010). However the molecular mechanisms of the 
interacting components in this pathway in T. gondii are still not fully understood. 
Argonaute protein is the core component in the RNAi mechanism (Fire et al., 1998; Rand 
et al., 2004; Hutvagner and Simard, 2008). The elucidation of the different components 
and their molecular mechanism may eventually lead to development of potential drug 
targets that would prevent the parasitic infection. The current study was aimed to 
investigate the variants of the argonaute protein expressed by T. gondii and the 
contribution of argonaute protein to post transcriptional gene silencing pathway as well as 
its role in parasite growth and differentiation.   
            Previous studies by several research groups reported different sizes of argonaute 
protein expressed in T. gondii (databases from ToxoDB.org and NCBI) (Figure 1.5). The 
research groups reported the same sequences at the 3’ end of the argonaute transcript but 
their observations varied at the 5’ end (Figure 1.5). FASTA format of amino acid 
sequences for argonaute protein shown the C-terminal end is same, but the length of the 
N-terminal end varies (Figure 1.6). For this reason, the domain reported for argonaute 
exhibits a similar content for the catalytic PIWI and MID domain (C-terminal end 
domain) whereas the PAZ domain and N- terminal shows the discrepancy (Figure 1.6). 
Therefore, it was of interest to study the possibility that T. gondii express multiple forms 
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of argonaute. It is possible that multiple forms could arise from multiple transcript 
variants from alternative splicing of the primary transcript, or multiple proteins from the 
use of different start codons on the transcript. Notably, a few studies have suggested that 
T. gondii may utilize alternative splicing mechanism as a means of post transcriptional 
gene regulation (Suvorova and White, 2014). However, others have reported 2.5 kb 
single transcript for argonaute after northern blot analysis by using DIG-labeled probe 
prepared from the sequences correspondent to the internal PIWI domain (Al Riyahi et al., 
2006).    
            Type 1 parasite (RH∆HX) was used for this experiment because it is more 
virulent and optimal for rapid replication and efficiency of lysing host cells, which allows 
for isolation of  large amounts of parasites (Saeij et al., 2005). This study is the first to 
describe a comprehensive analysis of argonaute transcript variants in T. gondii. Using 
multiple overlapping PCR primer sets, we identified single variant of transcript for 
TgAgo which correlates with the length reported from Barik research group (marked as 2 
in the Figure 1.5). Additionally, no splice variants of the transcript were observed from 
the investigation, which also correlates with the northern blot report by Al Riyahi et al., 
(2006).   
            Moreover, we also demonstrated that T. gondii expresses single form of argonaute 
protein by immunoblot analysis (Figure 3.2), and the molecular weight of the argonaute 
is ~ 58.5 kDa, which is similar to the size to that reported by Al Riyahi et al., (2006). 
However, the length of the transcript detected correlates with Barik research group 
(GenBank accession no. DQ177874, marked as 2 in the Figure 1.5) but according to that 
sequence the calculated molecular weight supposed to be around ~83 kDa. So, it can be 
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assume that the 5’ UTR might be longer than the length reported by Al Riyahi et al., 
(2006), which spans from exon 3-5 whereas the coding sequence is from exon 6 to 7. 
This shows that T. gondii expresses a single species of argonaute that is shorter than most 
other eukaryotes. In vitro RNA cleavage assay with TgAgo mutant with deleted different 
portions of N-terminus showed that the cleavage activity of argonaute was conserved as 
long as the putative PIWI domain was intact (Musiyenko et al., 2012). Furthermore, 
archeal argonaute protein from Archaeoglobus fulgidus lacks PAZ domain but crystal 
structure revealed that amino acid residues at the N- terminus can form a domain which 
can bind with siRNA and guide the RISC complex (Ma et al., 2005). Moreover, Song et 
al. (2004) mentioned that PAZ domain is poorly conserved and not easy to detect from 
the primary amino acid sequences. Thus, N-terminal amino acid sequences from short 
version of TgAgo could form a PAZ like fold. In that case, crystallographic analysis may 
disclose the argonaute folding structure during the silencing activity or if PAZ domain is 
absent further study will be fascinating to analyze TgAgo, that how TgAgo works in 
absence of PAZ domain?     
            Argonaute protein is an important component in RISC complex in RNAi pathway 
for post transcriptional gene regulation in many organisms including different protozoan 
parasites (Ullu et al., 2004; Hutvagner and Simard, 2008; Meister, 2013). MiRNAs are an 
important factor in gene silencing pathways where miRNAs guide the RISC complex 
towards mRNA and bind with mRNA by sequence complementarity (either perfect or 
near-perfect complementary binding) (Carthew, 2006; Zhang et al., 2007; Ghildiyal and 
Zamore, 2009; Braun et al., 2010). Furthermore, previous studies from our group 
demonstrated that the introduction of a luciferase plasmid construct with binding sites for 
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two highly expressed Tg-miRNA families, namely Tg-miR-60a (Rn60a) and Tg-miR-4a 
(Rn4a), exhibited silencing of the luciferase expression  by endogenous Tg-miRNAs in T. 
gondii RH∆HX strains (Crater et al., 2015). My results revealed a silencing effect on 
luciferase expression in RH∆HX strains. However, in AGOKO strains the silencing 
ability was reduced (Figure 3.4). This observation suggests that argonaute has a major 
contribution in RNAi based gene silencing pathway in T. gondii. Further studies of the 
molecular mechanism and associated components of RNAi silencing pathways will 
undoubtedly reveal a great surprise.  
            Argonaute proteins are associated with developmental processes in diverse 
organisms (Carmell et al., 2002). Reduction of argonaute expression in Drosophila and C. 
elegans produces defective germlines (Cox et al., 2000; Tijsterman et al., 2002). Hence, 
it has been speculated that absence of argonaute expression in T. gondii may lead to 
effects on parasite growth. At 24 and 36 hours post infection an average doubling time is 
approximately 6-8 hours for both AGOKO and wild type (RH∆HX) strains (Figure 3.5), 
which is also similar to previously reported values for wild type strain (Black and 
Boothroyd, 2000), suggesting that reduction of argonaute expression does not affect T. 
gondii growth.  
            To monitor if knock out of argonaute expression has any influence on bradyzoite 
differentiation, my experimental findings demonstrated that AGOKO strains formed 
around 40% more cyst structures than the parental RH∆HX, which verified that 
argonaute expression inhibits bradyzoite conversion (Figure 3.6).  
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            Taken together, the results presented in this thesis indicate that T. gondii 
expresses single species of argonaute protein which is shorter than most other eukaryotes. 
The knockout of TgAgo expression resulted in a reduction in silencing ability which 
suggests that argonaute has a major contribution in RNAi based gene silencing pathway 
in T. gondii. It was also observed that TgAgo plays a role in differentiation since the 
knockout of argonaute expression resulted in an increase in bradyzoite formation. 
Following this result, future work might be directed to determine the possible functional 
domain of TgAgo, by utilizing knockin studies of various argonaute variants truncated 
for specific domains in AGOKO strains and monitor if argonaute complements the 
function in the AGOKO strain.    
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Appendix A 
 
 
a) Primer sets used for TgAgo transcript analysis 
 
f : 869 bp RGG5Ago: 
GGGAATTCAATGAACGGAGGAGGCAGA 
AGO Exon 4_Rv: 
GACAAGTCCACCATTCG 
g : 393 bp RGG5Ago: 
GGGAATTCAATGAACGGAGGAGGCAGA 
AGO Exon 2_Rv: 
CGCGAGATGGCCCAAGG 
h : 1179 bp RGG5Ago: 
GGGAATTCAATGAACGGAGGAGGCAGA 
AGOexon5_rev: 
GTATGCCGGGCGATCC 
 
Table: PCR Primer sets for analyzing the TgAgo transcript  
 
 
 
 
 
Primer labels correspond to 
those in Figure 3.2: A and B 
Primer sets (5’→3’) 
a : 860 bp TgArg5'end: CCGCAGTATTTCGCAAATG 
TgArg3'end: GCTTCGCCACTGAGGTGAG 
b : 816 bp 5'TgAgoNsiI:  
TTTATGCATATCATGCCTCCC CG 
GSP-Argo: CGCACACACAATGGGCGCTG 
c : 298 bp AGOexon4_fw:  
CCGTTTCGATCTGCA 
Ext_Ago5RACE:  
CGG GGC TGA ATG TCC CTG 
d : 570 bp Barik_TgAgo5':  
ATGGAGGGAT ACCAAATGTT CC 
AGOexon5_rev: 
GTATGCCGGGCGATCC 
e : 738 bp Barik_TgAgo5':  
ATGGAGGGAT ACCAAATGTT CC 
Ext_Ago5RACE:  
CGG GGC TGA ATG TCC CTG 
AGOexon5_rev: 
GTATGCCGGGCGATCC 
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Appendix B 
 
 
 
 
 
 
 
 
 
 
 
 
Figure B1: Illustration of pAGO-SF-TAP-LIC-HX transgenic plasmid. 3ʹ end 
genomic sequence fragment of argonaute gene (TGGT1_310160) was acquired by PCR 
analysis from T. gondii Type I strain. The location of strep and FLAG tags are shown. 
The HXGPRT cassette is also indicated which was used for transgenic parasite selection. 
Moreover, single cutting site of restriction enzyme is also marked, which was used to 
linearize the plasmid.  
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Figure B2: Illustration of pAGOKO transgenic plasmid. 5’ end and 3’ end flanking 
genomic sequence fragment of argonaute gene from T. gondii Type I strain (shown in 
green). The location of the HXGPRT cassette (backward orientation) is indicated, which 
was used for knock out of argonaute genomic sequence. The location of coding sequence 
for the GFP tag is also shown. 
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Figure B3: Illustration of pGEM-T easy cloning vector. Linearized vectors with a 
single 3´-terminal thymidine at both ends (shown in figure). The vector contains T7 and 
SP6 RNA polymerase promoters flanking a multiple cloning region within the α-peptide 
coding region of the enzyme β-galactosidase. The location of the coding sequence for 
ampicillin resistance is also shown, used for drug selection.  
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